9 November 2021 With October being a month dedicated to promoting liver cancer awareness, EASL participated in numerous relevant activities. EASL leadership played a key role notably in two high-level advocacy events, coming to the heart of advocacy. The European Commission’s “Beating Cancer Pla…
5 November 2021 EASL, the European Society for Organ Transplantation (ESOT) with the European Liver and Intestine Transplantation Association (ELITA), and the International Liver Transplantation Society (ILTS), are calling transplant centres across the globe to share their experiences of offering…
2 November 2021 EASL, the European Society for Organ Transplantation (ESOT) with the European Liver and Intestine Transplantation Association (ELITA), and the International Liver Transplantation Society (ILTS), are proud to announce the publication of findings of a jointly run survey held from Se…
22 October 2021 Since 2020 EASL Studio has been a part of the International Liver Congress (ILC), bringing you the most up-to-date research live from the congress. But EASL Studio is evolving. EASL Studio is now a new platform through which we will be exploring hepatology every week, from every a…
EASL’s engagement with nurses and Allied Health Professionals (AHPs) has been thriving through 2021. Their next contribution for the global liver community is a webinar by the EASL Nurses and AHPs Task Force in which they will be sharing their expertise on managing NAFLD in patients. Key inform…
EASL’s International Liver Congress™ (ILC) 2022 will be taking place in London, UK, 22–26 June 2022. Delegates can attend in person or remotely. This first-in-class, international event is running for the 57th time and is the largest annual event on the hepatology calendar. This event, run by the…
Together with 21 international medical societies EASL strongly reaffirms the essential values held by the global community of transplant providers. We stand against any form of barriers in access, knowledge, transition and required training around organ donation. We back the worldwide call to act…
17 September 2021 On 14 September 2021, EASL, in its role as non-state actor in official relations with the World Health Organization (WHO), provided a joint statement on matters of considerable importance in liver care: primary health care and keeping viral hepatitis elimination clearly on the a…
15 September 2021 It is with great sadness that EASL announces the passing of Prof. Peter L.M. Jansen, devoted to cholestatic and metabolic liver disease, a longstanding member of the EASL community, and an inspiration to the hepatology community. We send our sincere condolences to his family and…
14 September 2021 On 16 October 2021, the best of ILC 2021 will be showcased at an online event jointly run by EASL and the Turkish Association for the Study of the Liver (TASL), called the Best of EASL ILC at TASL: Clinical Innovations and Controversies in ILC 2021. This meeting is co-organise…
